High-Dose edatrexate with oral leucovorin rescue: A phase I and clinical pharmacological study in adults with advanced cancer

Clinical Cancer Research

Volumn 2, Issue 11, 1996, Pages 1819-1824

  Pisters, Katherine M W ^a,b   Tyson, Leslie B ^b   Tong, William ^b   Fleisher, Martin ^b   Miller, Vincent A ^b   Grant, Stefan C ^b   Pfister, David G ^b   Rigas, James R ^b   Densmore, Christine L ^b   Krol, George ^b   Heelan, Robert T ^b   Sirotnak, Francis M ^b   Bertino, Joseph R ^b   Kris, Mark G ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDATREXATE; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOENCEPHALOPATHY; LEUKOPENIA; MALE; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; STOMATITIS;

ADMINISTRATION, ORAL; ADULT; AGED; AMINOPTERIN; ANTINEOPLASTIC AGENTS; DRUG INTERACTIONS; DRUG MONITORING; FEMALE; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASMS;

EID: 10544232609     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sirotnak, F. M., DeGraw, J. I., and Moccio, D. M. New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models. Cancer Chemother. Pharmacol., 12: 26-30, 1984.
2. Schmid, F. A., Sirotnak, F. M., and Otter, G. M. New folate analogs of the 10-deaza-aminopterin series. Markedly increased activity of the 10-ethyl analogue compared to the parent compound and methotrexate against some human tumor xenografts in nude mice. Cancer Treat. Rep., 69: 551-553, 1985.
3. Sirotnak, F. M., DeGraw, J. I., Moccio, D. M., Samuels, L. L., and Goutas, L. J. New folate analogues of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties. Cancer Chemother. Pharmacol., 12: 18-25, 1984.
4. Kris, M., Kinahan, J., Gralla. R., Fanucchi, M. P., Wertheim, M. S., O'Connell, J. P., Marks, L. D., Williams, L., Farag, F., Young, C. W., and Sirotnak, F. M. Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer. Cancer Res., 48: 5573-5579, 1988.
5. Shum, K., Kris, M., Gralla, R., Burke, T., Marks, L., and Heelau, R. Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small cell lung cancer. J. Clin. Oncol., 6: 446-450, 1988.
6. Lee, J. S., Libshitz, H. I., Murphy, W. K., Dhingra, H. M., Shirinian, M., Holoye, P. Y., and Hong. W. K. Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIb or IV non-small cell lung cancer. Invest. New Drugs, 8: 299-304, 1990.
7. Sirotnak, F. M., Otter, G. M., and Schmid, F. A. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen and leucovorin rescue against metastatic murine solid tumors. Cancer Res., 53: 587-591, 1993.
8. Pitman, S. W., and Frei, E. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat. Rep., 61: 695-701, 1977.
9. Stoller, R. G., Jacobs, S. A., and Drake, J. C. Pharmacokinetics of high-dose methotrexate (NSC-740). Cancer Chemother. Rep., 6: 19-24. 1975.
10. Rosen, G., Caparros, B., and Huvos, A. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative non-otherapy. Cancer (Phila.), 49: 1221-1230, 1982.
11. Miller, A. B., Hoogstraten, B., Staquet, M., and Winkler, A. Reporting results of cancer treatment. Cancer (Phila.), 47: 207-214, 1981.
12. Gabrielsson, J., and Weiner, D. Pharmacokinetic/Pharmacodynamic Data Analysis: Concept and Application, p. 622. Stockholm: Swedish Pharmaceutical Press, 1994.
13. Meadows, A. T., and Evans, A. E. Effects of chemotherapy on the central nervous system: a study of parenteral methotrexate in long-term survivors of leukemia and lymphoma in childhood. Cancer (Phila.), 37: 1079-1086, 1976.
14. Allen, J. C., Rosen, G., Mehta, B. M., and Horton. B. Leukoencephalopathy following high dose IV methotrexate chemotherapy with leucovorin rescue. Cancer Treat. Rep., 64: 1261-1273, 1980.
15. Winter, M. E. Basic Clinical Pharmacokinetics, p. 204. Spokane, WA: Applied Therapeutics, Inc., 1988.
16. Allegra, C. J. Antifolates in Cancer Chemotherapy Principles and Practice, pp. 110-153. Philadelphia: Lippincott Publishers, 1990.